Beijing Inno Medicine Co., Ltd.

This study tests a drug called YN001 in 456 adults with coronary atherosclerosis (plaque buildup in heart arteries). Participants receive weekly injections of YN001 or a placebo for 13 weeks. The main goal is to see if YN001 reduces plaque volume in the arteries, as measured by a…

This study tests a new medicine called YN001 in people with coronary atherosclerosis (hardening of the arteries in the heart). The goal is to see if YN001 can reduce plaque buildup in the arteries when added to standard care. About 24 adults in Australia with at least one blocked…

This early-phase trial is testing a new drug called YN001 in 24 healthy adults. Researchers want to see how the drug moves through the body, how long it stays, and whether it causes any side effects. Participants receive a single dose by IV and are monitored closely. This study d…